z-logo
open-access-imgOpen Access
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Author(s) -
Robert Gottlieb,
Carlos Vaca,
Roger Paredes,
Jorge Mera,
Brandon Webb,
Gilberto Perez,
Godson Oguchi,
Pablo Ryan,
Bibi Uhre Nielsen,
Martin M. Brown,
Adriana Carolina Correa Hidalgo,
Yessica Sachdeva,
Shilpi Mittal,
Olayemi Osiyemi,
Jacek Skarbinski,
Kavita Juneja,
Robert H. Hyland,
Anu Osinusi,
Shuguang Chen,
Grégory Camus,
Mazin Abdelghany,
Santosh Davies,
Nicole Behenna-Renton,
Franck Le Duff,
Francisco M. Marty,
Morgan J. Katz,
Adit A. Ginde,
Samuel M. Brown,
Joshua T. Schiffer,
Joshua A. Hill
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2116846
Subject(s) - medicine , placebo , clinical endpoint , randomization , covid-19 , adverse effect , diabetes mellitus , randomized controlled trial , risk factor , clinical trial , disease , surgery , pathology , infectious disease (medical specialty) , alternative medicine , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom